New
GS Foundation (P+M) - Delhi : 10th Feb. 2026, 10:30 AM Spring Sale UPTO 75% Off GS Foundation (P+M) - Prayagraj : 15th March 2026 Spring Sale UPTO 75% Off GS Foundation (P+M) - Delhi : 10th Feb. 2026, 10:30 AM GS Foundation (P+M) - Prayagraj : 15th March 2026

Semaglutide: Mechanism, Uses, Significance, Side-effects & Challenges

Why in News ?

  • Hyderabad-based Natco Pharma has recently received approval from the Central Drugs Standard Control Organization (CDSCO) to manufacture and market a generic Semaglutide injection in India.
  • Earlier, the drug was extremely expensive and accessible only to a limited population.
  • Generic availability may significantly transform diabetes and obesity management in India.


What is Semaglutide ?

Semaglutide is an anti-diabetic and anti-obesity medication belonging to the class of drugs called GLP-1 Receptor Agonists (GLP-1 RA).

What is GLP-1 ?

GLP-1 (Glucagon-Like Peptide-1) is a hormone released from the intestine after eating.
It helps regulate blood sugar, appetite, and metabolism.

Mechanism of Action

Semaglutide mimics the natural GLP-1 hormone in the body:

Action

Effect

Increases insulin secretion from pancreas

Lowers blood sugar

Suppresses glucagon

Reduces glucose production

Slows gastric emptying

Reduces hunger

Acts on brain appetite centers

Causes weight loss

Therefore, it is considered a metabolic disease drug, not just a sugar-control medicine.

Therapeutic Uses (Indications)

(A) Type-2 Diabetes

  • Controls blood glucose
  • Reduces insulin resistance
  • Effective in long-term HbA1c reduction

(B) Cardiovascular Risk Reduction

In adults with diabetes + heart disease:

  • Reduces heart attack risk
  • Reduces stroke risk
  • Lowers cardiovascular mortality

(C) Kidney Disease

In Type-2 diabetes with kidney involvement:

  • Slows kidney failure progression
  • Reduces death risk

(D) Obesity Treatment

WHO recognizes obesity as a chronic metabolic disease.

Semaglutide:

  • Suppresses appetite
  • Reduces calorie intake
  • Produces 10–20% weight loss in clinical trials

 Often called a “medical weight-loss revolution therapy.”

Global Significance

Semaglutide is termed a “weight-loss revolution drug” due to:

  • Global obesity epidemic
  • Rising diabetes burden
  • Increasing lifestyle diseases

Importance for India

  • India is often called the diabetes capital of the world (International Diabetes Federation estimates)
  • Rising obesity & cardiovascular diseases make this drug highly relevant.

Available Forms

  • Weekly injection
  • Oral tablet (available in some countries)

Side Effects

Common

Serious (Rare)

Nausea, vomiting

Pancreatitis

Constipation

Gallbladder disease

Abdominal pain

Possible thyroid tumor risk (animal studies)

Importance for India

1. Generic Availability

Approval for Natco Pharma may:

  • Reduce cost
  • Improve middle-class access
  • Enable public health program use

2. Role in NCD Control

Helps control:

  • Diabetes
  • Obesity
  • Cardiovascular diseases

Challenges

  • Not a substitute for lifestyle modification
  • Long-term safety data still evolving
  • Risk of misuse for cosmetic weight loss
  • Dependence on expensive chronic therapy
Have any Query?

Our support team will be happy to assist you!

OR
X